Neoadjuvant Chemotherapy Followed by Surgery for Advanced-Stage Endometrial Cancer
Author(s) -
Norbert Lange,
N Ezendam,
Janice S. Kwon,
Ingrid Vandenput,
D. Mirchandani,
Frédéric Amant,
Louis J.M. van der Putten,
Johanna M.A. Pijnenborg
Publication year - 2019
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.26.4655
Subject(s) - medicine , debulking , serous fluid , stage (stratigraphy) , endometrial cancer , oncology , chemotherapy , serous carcinoma , surgery , cancer , ovarian cancer , paleontology , biology
Data showing the value of neoadjuvant chemotherapy (nact) followed by interval debulking surgery (ids) in the management of advanced-stage serous endometrial carcinoma (eca) are limited; the aim of the present study was to expand the knowledge about that treatment strategy in patients with advanced eca, including endometrioid eca.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom